Mark A Varney - Net Worth and Insider Trading

Mark A Varney Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark A Varney owns 1 companies in total, including RespireRx Pharmaceuticals Inc (RSPI) .

Click here to see the complete history of Mark A Varney’s form 4 insider trades.

Insider Ownership Summary of Mark A Varney

Ticker Comapny Transaction Date Type of Owner
RSPI RespireRx Pharmaceuticals Inc 2006-01-30 Chief Scientific Officer

Mark A Varney Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark A Varney Ownership Network

Ownership Network List of Mark A Varney

No Data

Ownership Network Relation of Mark A Varney

Insider Network Chart

Mark A Varney Owned Company Details

What does RespireRx Pharmaceuticals Inc do?

Who are the key executives at RespireRx Pharmaceuticals Inc?

Mark A Varney is the Chief Scientific Officer of RespireRx Pharmaceuticals Inc. Other key executives at RespireRx Pharmaceuticals Inc include SVP of Pre-Clinical Prod. Dev. David Dickason , director & CEO and President Timothy L. Jones , and director & President & CEO Manuso James S J .

RespireRx Pharmaceuticals Inc (RSPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of RespireRx Pharmaceuticals Inc (RSPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RespireRx Pharmaceuticals Inc (RSPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

RespireRx Pharmaceuticals Inc (RSPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RespireRx Pharmaceuticals Inc Insider Transactions

No Available Data

Mark A Varney Mailing Address

Above is the net worth, insider trading, and ownership report for Mark A Varney. You might contact Mark A Varney via mailing address: 15241 Barranca Parkway, Irvine Ca 92618.

Discussions on Mark A Varney

No discussions yet.